Ligand Pharmaceuticals
LGND
#2962
Rank
โ‚ฌ4.91 B
Marketcap
246,72ย โ‚ฌ
Share price
-0.43%
Change (1 day)
70.63%
Change (1 year)

Earnings for Ligand Pharmaceuticals (LGND)

Earnings in 2026 (TTM): โ‚ฌ0.16 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's current earnings are โ‚ฌ0.27 Billion. In 2025 the company made an earning of โ‚ฌ0.14 Billion, an increase over its 2024 earnings that were of โ‚ฌ4.83 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ligand Pharmaceuticals from 1994 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚ฌ0.16 B13.69%
2025 โ‚ฌ0.14 B2848.57%
2024 โ‚ฌ4.83 M-91.37%
2023 โ‚ฌ55.97 M-7.59%
2022 โ‚ฌ60.57 M4%
2021 โ‚ฌ58.24 M296.42%
2020 โ‚ฌ14.69 M-97.97%
2019 โ‚ฌ0.72 B275.62%
2018 โ‚ฌ0.19 B237.48%
2017 โ‚ฌ57.14 M49.05%
2016 โ‚ฌ38.34 M55.41%
2015 โ‚ฌ24.67 M36.87%
2014 โ‚ฌ18.02 M29.59%
2013 โ‚ฌ13.9 M1309.35%
2012 โ‚ฌ0.98 M-43.97%
2011 โ‚ฌ1.76 M-113.19%
2010 -โ‚ฌ13.36 Million59.86%
2009 -โ‚ฌ8.36 Million-61.33%
2008 -โ‚ฌ21.61 Million-58.75%
2007 -โ‚ฌ52.38 Million20.52%
2006 -โ‚ฌ43.46 Million81.27%
2005 -โ‚ฌ23.98 Million
2003 -โ‚ฌ16.69 Million-20.6%
2002 -โ‚ฌ21.02 Million4.38%
2001 -โ‚ฌ20.14 Million-48.83%
2000 -โ‚ฌ39.35 Million-19.74%
1999 -โ‚ฌ49.03 Million-19.06%
1998 -โ‚ฌ60.58 Million126.71%
1997 -โ‚ฌ26.72 Million-5.83%
1996 -โ‚ฌ28.38 Million136.23%
1995 -โ‚ฌ12.02 Million-33.97%
1994 -โ‚ฌ18.19 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ22.60 B 13,538.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ9.21 B 5,460.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ27.08 B 16,240.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ7.90 B 4,670.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-โ‚ฌ0.45 Billion-366.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ11.44 B 6,804.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ8.35 B 4,938.43%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚ฌ8.71 B 5,155.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-โ‚ฌ53.86 Million-132.49%๐Ÿ‡บ๐Ÿ‡ธ USA